Oncogenes |
BRAF, FYN, KIT, KRAS, MET, MFHAS1, MYC, NRAS, PDGFRA, PIM1, SPI1 |
Anti-oncogene |
AIM1, PRDM1, PTEN, ST5, TP53 |
Apoptosis |
BCL2, CARD11, FAS, TNFAIP3, TNFRSF14 |
Cell cycle |
CCND1, CDKN2A, CDKN2B, XPO1 |
Immune response |
CD58, CD79A, CD79B, CXCR4, IGHD, IGHJ, KIR2DL4, KIR3DL2 |
Transcriptional regulation |
BCL6, ID3, IRF4, TCF3, DDX3X |
DNA methylation |
DNMT3A, DNMT3B, TET2 |
Histone acetylation |
BCOR, CREBBP, EP300 |
Histone methylation |
KMT2D, EZH2 |
Signaling pathways |
NOTCH1, NOTCH2, STAT3, STAT6, CTNNB1, SOCS1, GNA13 |
Receptor tyrosine kinase |
ALK |
Autophagy |
ATG5 |
Homeostasis |
FOXO1, FOXO3 |
Others |
IDH2, ITPKB, MEF2B, MYD88, RHOA, B2M, CIITA |